Health Canada’s regulatory response to COVID-19: Access to health products

Health Canada’s regulatory response to COVID-19: Access to health products As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards. 2021-06-30 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19pandemicHealth Canada’s regulatory responseregulatory measuresexpedite the regulatory reviewaccess to health products Health Canada’s regulatory response to COVID-19: Access to health productsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/regulatory-response-health-product-access.html Health Canada’s regulatory response to COVID-19: Access to health productsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/reponse-reglementation-acces-produits-sante.html

As part of the government's broad response to the pandemic, Health Canada introduced innovative and agile regulatory measures. These measures expedite the regulatory review of COVID-19 health products without compromising safety, efficacy and quality standards.

Data and Resources

Similar records